Showing results (881-890 of 1,142) with videos related to

Sort By:
Pageof 115
Abdominal Radiology (New York)|November 5, 2024
Percutaneous transhepatic biliary drainage in patients with cholestasis following liver transplantationThorben Pape, Tabea von Garrel, Anna M Hunkemöller, et al.
Gut|May 26, 2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genomeDaniel Todt, Anett Gisa, Aleksandar Radonic, et al.
Clinical and Molecular Hepatology|June 4, 2025
Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapyMoana Witte, Carlos Oltmanns, Jan Tauwaldt, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 16, 2025
The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conferenceB Schug, G Beuerle, E Bilensoy, et al.
Plos One|November 9, 2013
High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern VietnamBui Tien Sy, Boris A Ratsch, Nguyen Linh Toan, et al.
Zeitschrift Fur Gastroenterologie|February 11, 2020
Treatment-failure to direct antiviral HCV regimens in real world: frequency, patient characteristics and rescue therapy - data from the German hepatitis C registry (DHC-R)Annika Schmitt, Rainer Günther, Stefan Mauss, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2018
The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patientsD Attia, K El Saeed, W Elakel, et al.
Plos One|December 14, 2017
Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidenceJoshua W Smith, Maria F Kroker-Lobos, Mariana Lazo, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|November 20, 2012
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitisGökhan Kabaçam, George N Dalekos, Yılmaz Çakaloğlu, et al.
Zeitschrift Fur Gastroenterologie|September 18, 2020
Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)Johannes Vermehren, Yvonne Serfert, Markus Cornberg, et al.
Pageof 115